While tirzepatide is a dual-action medication (targeting GLP-1 and GIP), semaglutide mimics one hormone, GLP-1, which regulates appetite, slows digestion, and triggers insulin release
Side effects with Wegovy 7.2 mg The STEP UP trial found that side effects were somewhat more common at the 7.2 mg dose than at 2.4 mg: 2 GI side effects: 70.8% (7.2 mg) vs 61.2% (2.4 mg) Dysaesthesia (tingling or numbness): 22.9% (7.2 mg) vs 6.0% (2.4 mg) Discontinuation due to side effects remained low at 3.3% The dysaesthesia finding is notable, though 85.7% of cases resolved while continuing treatment
A 2017 Cochrane Review involving 27 studies and 3,408 patients compared the use of buprenorphine for opioid withdrawal compared to other interventions including methadone, alpha2-adrenergic agonists, symptomatic management, or placebo
Semaglutide injections have been observed to provide weight loss benefits, even in individuals who do not have diabetes
While it may have benefits, there isnt strong proof that it works well for skin whitening